NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11 | +22.2% | 1,496 | +20.0% | 0.00% | – |
| Q2 2023 | $9 | +12.5% | 1,247 | +8.8% | 0.00% | – |
| Q1 2023 | $8 | -42.9% | 1,146 | -18.4% | 0.00% | – |
| Q4 2022 | $14 | -99.9% | 1,405 | +72.6% | 0.00% | – |
| Q3 2022 | $15,000 | -51.6% | 814 | +37.0% | 0.00% | – |
| Q2 2022 | $31,000 | -32.6% | 594 | -4.5% | 0.00% | – |
| Q1 2022 | $46,000 | -76.6% | 622 | -54.9% | 0.00% | -100.0% |
| Q4 2021 | $197,000 | +47.0% | 1,378 | +117.7% | 0.00% | 0.0% |
| Q2 2021 | $134,000 | 0.0% | 633 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $134,000 | 0.0% | 633 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $134,000 | 0.0% | 633 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $134,000 | 0.0% | 633 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $134,000 | 0.0% | 633 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $134,000 | 0.0% | 633 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $134,000 | 0.0% | 633 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $134,000 | 0.0% | 633 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $134,000 | 0.0% | 633 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $134,000 | – | 633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 90,000 | $4,629,000 | 1.95% |
| Affinity Asset Advisors, LLC | 85,000 | $4,372,000 | 1.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,814 | $132,500,000 | 1.38% |
| Mendel Capital Management LLC | 23,835 | $1,226,000 | 1.37% |
| Faithward Advisors, LLC | 80,143 | $4,122,000 | 0.92% |
| Coatue Management | 1,241,716 | $63,861,000 | 0.77% |
| Rock Springs Capital Management LP | 475,100 | $24,434,000 | 0.71% |
| SECTOR GAMMA AS | 55,324 | $2,845,000 | 0.64% |
| SevenOneSeven Capital Management | 5,103 | $262,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 49,200 | $2,530,000 | 0.51% |